Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Baxter
Moodys
Colorcon
AstraZeneca

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ESTRADIOL VALERATE AND DIENOGEST

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Estradiol Valerate And Dienogest

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00293059 Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding Completed Bayer Phase 3 2005-12-01 The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.
NCT00307801 Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding Completed Bayer Phase 3 2006-02-01 The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.
NCT00335218 Fat Distribution in Healthy Early Postmenopausal Women Completed Bayer Phase 4 2002-07-01 The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging.
NCT00764881 Effects of SH T00658ID on Libido Completed Bayer Phase 3 2009-01-01 The aim of the study is to investigate whether women on oral contraceptives (OCs) suffering from acquired OC-associated female sexual dysfunction (FSD) for at least 3 months but no longer than one year will express the same level of sexual distress when taking SH T00658ID compared to Microgynon, the usual OC prescribed for women with OC-associated FSD.
NCT00778609 Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache Completed Bayer Phase 3 2008-12-01 The aim of the present study is to investigate whether women taking a new combined oral contraceptive pill (SH T00658ID, estradiol valerate/dienogest) experience fewer hormone withdrawal-associated symptoms such as pelvic pain or headache during their monthly cycle compared to a commonly used contraceptive pill (Microgynon).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Estradiol Valerate And Dienogest

Condition Name

Condition Name for Estradiol Valerate And Dienogest
Intervention Trials
Contraception 4
Metrorrhagia 3
Pelvic Pain 1
Headache 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Estradiol Valerate And Dienogest
Intervention Trials
Hemorrhage 3
Metrorrhagia 3
Uterine Hemorrhage 2
Endometriosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Estradiol Valerate And Dienogest

Trials by Country

Trials by Country for Estradiol Valerate And Dienogest
Location Trials
United States 20
China 20
Germany 18
Australia 11
United Kingdom 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Estradiol Valerate And Dienogest
Location Trials
Florida 1
Oregon 1
Illinois 1
Indiana 1
Nevada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Estradiol Valerate And Dienogest

Clinical Trial Phase

Clinical Trial Phase for Estradiol Valerate And Dienogest
Clinical Trial Phase Trials
Phase 4 4
Phase 3 6
Phase 2 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Estradiol Valerate And Dienogest
Clinical Trial Phase Trials
Completed 11
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Estradiol Valerate And Dienogest

Sponsor Name

Sponsor Name for Estradiol Valerate And Dienogest
Sponsor Trials
Bayer 10
Bagcilar Training and Research Hospital 1
Suleymaniye Birth And Women's Health Education And Research Hospital 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Estradiol Valerate And Dienogest
Sponsor Trials
Industry 11
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
McKesson
AstraZeneca
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.